PDL BioPharma (PDLI) Reports Q4 EPS of $0.26; Declares Two Qtr. Dividends of $0.50/Share
Tweet Send to a Friend
PDL BioPharma (Nasdaq: PDLI) reports Q4 EPS of $0.26, versus the analyst estimate of $0.08. Revenues for ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
